The efficacy, pharmacokinetics, and safety of a nevirapine to rilpivirine switch in virologically suppressed HIV-1-infected patients

Publication year

2015

Author(s)

Source

JAIDS : Journal of Acquired Immune Deficiency Syndromes, 68, 1, (2015), pp. 36-9

ISSN

DOI

https://doi.org/10.1097/QAI.0000000000000363

Publication type

Article / Letter to editor

Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/154176

https://hdl.handle.net/2066/154176

Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.